Document is current
Any future updates will be listed below
-
Authors
Deshpande, Chandrika N.
Ruwe, T. Alex https://orcid.org/0000-0002-0629-9176
Shawki, Ali
Xin, Vicky
Vieth, Kyle R.
Valore, Erika V.
Qiao, Bo
Ganz, Tomas https://orcid.org/0000-0002-2830-5469
Nemeth, Elizabeta
Mackenzie, Bryan https://orcid.org/0000-0002-9661-8838
Jormakka, Mika https://orcid.org/0000-0002-2326-1735
- License Information
-
More Information
Article History
Received: 4 January 2018
Accepted: 5 July 2018
First Online: 6 August 2018
Change Date: 4 September 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
Competing interests
: T.G. and E.N. are scientific advisers to and shareholders in Intrinsic LifeSciences and Silarus Therapeutics, and consultants for La Jolla Pharmaceutical Company and Keryx Pharmaceuticals. B.M. is a grant recipient of Vifor Pharma. The remaining authors declare no competing interests.
